A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Key Market Players in the Indian Diabetes Care Market include Sanofi, Novo Nordisk India, USV, Novartis, Merck, Becton ...

Health2Sync's partnership with Western Sydney Diabetes is a significant step towards addressing the rising prevalence of ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and ...

Sanofi (SNY) says new data from three oral presentations demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Novo Nordisk to slash US prices of Tresiba and Fiasp insulins by over 70% from 2026, enhancing diabetes access. The company ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

Gymnast Jordan Chiles was engaged by Sanofi to advocate for type 1 diabetes screenings. She has a personal connection to the ...